Pharma giant Sanofi is enacting a name-change at its Waterford plant, bringing in 40 new staff as it changes the site’s name from Genzyme Waterford to Sanofi Waterford.
Sanofi’s Waterford plant is all go of late, with an imminent name change and an influx of staff just the latest in a long line of good news stories emerging from the facility.
Thought to already be employing over 600 people, the announcement of up to 40 new jobs at the site underlines the company’s position as a major employer in the region.
In 2013, €44m was put into the company’s new campus on the south coast to increase production of insulin product Lantus.
That brought the company’s total investment in Ireland to over €600m, according to The Irish Times. The majority of that was put in by Genzyme, which Sanofi Aventis SA bought in 2011 for some $20.1bn.
The global pharma giant’s Irish operations alone logged €1.55bn in revenues in the company’s most recent financials, and the Waterford facility was this year named among the best large workplaces in the country by the Great Place to Work programme.
Now changing the name from Genzyme Waterford to Sanofi Waterford, the company is aligning its operations globally, with the Irish change producing 40 jobs in the coming weeks – engineering and quality professionals are among the roles in question.
“Since Sanofi acquired Genzyme globally in 2011, the Waterford operation has been increasingly closely-integrated within Sanofi Industrial Affairs, so this is the logical next step as we plan for the future and build on the track record of achievement and growth here since 2001,” said Ruth Beadle, site head at Sanofi Waterford.
Looking for jobs in tech or science? Check out our Employer Profiles for information on companies hiring right now.
